| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.36 ▲ +1.68% | Yesterday | $1.33 ▼ -0.71% | Tomorrow's Quince Therapeutics Inc. Common Stock (QNCX) setup is anchored to $1.34 and targets $1.36 (+1.68%). The near-term read is upside; watch $1.38 / $1.30 because daily realized volatility is about 8.00%. |
Tomorrow's Quince Therapeutics Inc. Common Stock (QNCX) setup is anchored to $1.34 and targets $1.36 (+1.68%). The near-term read is upside; watch $1.38 / $1.30 because daily realized volatility is about 8.00%. | ||||
| Week | $1.41 ▲ +5.23% | Last Week | $1.31 ▼ -2.19% | The 7-day Quince Therapeutics Inc. Common Stock model moves from $1.31 to $1.41 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.38 / $1.30 matter more than a single tick. |
The 7-day Quince Therapeutics Inc. Common Stock model moves from $1.31 to $1.41 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.38 / $1.30 matter more than a single tick. | ||||
| Month | $1.49 ▲ +11.13% | Last Month | $1.28 ▼ -4.67% | The 1-month Quince Therapeutics Inc. Common Stock target is $1.49 (+11.13%), compared with the live reference near $1.34. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Quince Therapeutics Inc. Common Stock target is $1.49 (+11.13%), compared with the live reference near $1.34. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.61 ▲ +19.98% | Last Year | $1.23 ▼ -8.39% | The 1-year Quince Therapeutics Inc. Common Stock scenario points to $1.61 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Quince Therapeutics Inc. Common Stock scenario points to $1.61 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $1.89 ▲ +40.71% | 5 Years Ago | $1.11 ▼ -17.10% | The 5-year Quince Therapeutics Inc. Common Stock view is $1.89 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Quince Therapeutics Inc. Common Stock view is $1.89 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $1.34 | Mid |
| Daily Change | +5.51% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 69% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.34 | Daily Change | +5.51% |
| Market Cap | $21.84M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.